Surgery Partners, Inc. (SGRY) Forms Bullish Wedge Up Chart Pattern at $16.70

April 16, 2018 - By Yee Bell

Surgery Partners, Inc. (SGRY)’s chart reviews an up wedge chart setup with $17.20 price target. That’s 3.00 % above today’s $16.70 share price. The company’s valuation will be $24.35M more at $17.20 price target.

On during the last trading session the stock increased $0.2 or 1.21%, reaching $16.7.Surgery Partners, Inc. has volume of 31,297 shares. Since April 16, 2017 SGRY has declined 14.47% and is downtrending. The stock underperformed the S&P 500 by 26.02%.

Analysts await Surgery Partners, Inc. (NASDAQ:SGRY) to report earnings on May, 8. They expect $-0.22 earnings per share, down 650.00 % or $0.26 from last year’s $0.04 per share. After $-0.03 actual earnings per share reported by Surgery Partners, Inc. for the previous quarter, Wall Street now forecasts 633.33 % negative EPS growth.

Surgery Partners, Inc. (NASDAQ:SGRY) Ratings Coverage

In total 5 analysts cover Surgery Partners (NASDAQ:SGRY). “Buy” rating has 3, “Sell” are 0, while 2 are “Hold”. 60% are bullish. 5 are the (NASDAQ:SGRY)’s analyst reports since November 1, 2017 according to StockzIntelligence Inc. On Friday, November 10 the firm has “Buy” rating given by RBC Capital Markets. On Monday, November 13 Citigroup maintained Surgery Partners, Inc. (NASDAQ:SGRY) rating. Citigroup has “Buy” rating and $14 target. On Tuesday, October 31 the company was maintained by KeyBanc Capital Markets. On Wednesday, November 1 the company was downgraded by Bank of America. On Wednesday, November 1 Jefferies maintained Surgery Partners, Inc. (NASDAQ:SGRY) rating. Jefferies has “Buy” rating and $13 target.

Surgery Partners, Inc. (NASDAQ:SGRY) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: